Nav: Home

Current Placebo News and Events

Current Placebo News and Events, Placebo News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Study finds acetaminophen significantly reduced in-hospital delirium
Patients treated with acetaminophen demonstrated a significant reduction in in-hospital delirium. (2019-02-19)
UTMB develops drug to rejuvenate muscle cells
Researchers from The University of Texas Medical Branch at Galveston have developed a promising drug that has proven to significantly increase muscle size, strength and metabolic state in aged mice, according to a study just published in Biochemical Pharmacology. (2019-02-15)
Even psychological placebos have an effect
Placebo effects do not only occur in medical treatment -- placebos can also work when psychological effects are attributed to them. (2019-02-05)
Research pushes back on benefits of compounded topical pain creams
In an effort to reduce chronic pain, many people look for hope by paying $20 to thousands of dollars for a tube of prescription topical pain cream or gel. (2019-02-05)
Researchers report positive findings with dasotraline for ADHD in children ages 6-12
A new study in children aged 6 to 12 years of dasotraline, a promising new treatment for attention deficit hyperactivity disorder (ADHD), showed significant improvement in efficacy in the treatment of ADHD compared to placebo beginning at week 1 and continuing throughout the study. (2019-02-04)
New global task force report questions effectiveness of spinal fusion procedures, provides recommendations
There is little to no evidence that two surgical procedures used to fuse crumbled vertebrae following a spinal fracture caused by osteoporosis reduce pain for patients any better than non-surgical or placebo procedures, according to a new report from a global task force of bone health experts published today in the Journal of Bone and Mineral Research (JBMR). (2019-01-24)
First clinical study shows mavoglurant improves eye gaze behavior in fragile X syndrome patients
Researchers at Rush University Medical Center and the MIND Institute at UC Davis have found that mavoglurant, an experimental drug known as an mGluR5 negative modulator, can positively modify a key characteristic behavior in individuals with fragile X syndrome (FXS). (2019-01-17)
Poo transplant effective treatment for chronic bowel condition
Poo transplant or 'Faecal microbiota transplantation' (FMT) can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows. (2019-01-15)
B-group vitamins can improve concentration among people with first episode psychosis
The study, led by Dr Colin O'Donnell, now at Letterkenny University Hospital, and Dr Kelly Allott from Orygen, explored the impact of increasing a person's intake of vitamins B12, B6, and folic acid [vitamin B9] after studies in people with schizophrenia revealed that increased intake of these vitamins could decrease patients' levels of an amino acid called homocysteine and improve their symptoms. (2019-01-14)
Millions on prescription sleeping pills would sleep through a fire alarm
Widely prescribed 'benzodiazepine' sleeping pills suppress the sleeping brain's ability to wake us when it senses a threat. (2019-01-11)
Genetics may influence the effects of vitamin E on cancer risk
A new study led by researchers from Brigham and Women's Hospital investigated whether taking vitamin E supplements could affect risk of cancer and found that genetic variations in the gene COMT influenced whether vitamin E decreased or increased risk of developing cancer during and after the study periods. (2019-01-08)
Botulinum toxin reduces chronic migraine attacks, compared to placebo
A growing body of evidence supports the effectiveness of botulinum toxin injections in reducing the frequency of chronic migraine headaches, concludes an updated review and analysis in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS). (2019-01-03)
How exercise reduces belly fat in humans
Some of you may have made a New Year's resolution to hit the gym to tackle that annoying belly fat. (2018-12-27)
Opioids vs. placebo, nonopioid alternatives for chronic noncancer pain
An estimated 50 million adults in the United States were living with chronic noncancer pain in 2016 and many of them were prescribed opioid medications, even though a clinical benefit is uncertain. (2018-12-18)
Research finds opioids may help chronic pain, a little
In a study published today by the Journal of the American Medical Association (JAMA), McMaster University researchers reviewed 96 clinical trials with more than 26,000 participants and found opioids provide only small improvements in pain, physical functioning and sleep quality compared to a placebo. (2018-12-18)
Monitoring lung function at home in teens with Duchenne muscular dystrophy
Heart and lung complications are responsible for much of the morbidity and mortality associated with Duchenne muscular dystrophy (DMD). (2018-12-17)
Probiotics could help millions of patients suffering from bipolar disorder
About 3 million people in the US are diagnosed every year with bipolar disorder, a psychiatric condition characterized by dramatic shifts in mood from depression to mania. (2018-12-13)
The Lancet Neurology: Cannabis-based drug in combination with other anti-spasticity
Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs. (2018-12-13)
Oxybutynin decreased frequency of hot flashes, improved QOL for breast cancer survivors
Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could not take hormone replacement, including breast cancer survivors, according to results of a trial presented at the 2018 San Antonio Breast Cancer Symposium. (2018-12-07)
Mayo-led study: Drug reduces hot flashes, improves breast cancer survivor quality of life
Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. (2018-12-07)
Low-dose tamoxifen reduced recurrence and new disease for patients with DCIS, LCIS, and ADH
Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease recurrence and new disease for women who had been treated with surgery following a diagnosis of breast intraepithelial neoplasia compared with placebo, and it did not cause more serious adverse events, according to data from the randomized, phase III TAM-01 clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. (2018-12-06)
Liquid biopsies in SOLAR-1 trial predict benefit of Alpelisib in PIK3CA-mutant breast cancer
Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared with analysis of tissue biopsy in breast cancer patients enrolled in the phase III clinical trial SOLAR-1, according to data presented at the 2018 San Antonio Breast Cancer Symposium. (2018-12-06)
Pot withdrawal eased for dependent users
A new drug can help people diagnosed with cannabis use disorder reduce withdrawal symptoms and marijuana use, a new Yale-led study published Dec. (2018-12-06)
Cannabis-based compound may reduce seizures in children with epilepsy
Interest has been growing in the use of cannabinoids--the active chemicals in cannabis or marijuana-- for the treatment of epilepsy in children. (2018-12-05)
Common antidepressant does not aid stroke recovery, study finds
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study led by the University of Edinburgh has found. (2018-12-05)
Cleveland Clinic-led study: Rivaroxaban reduced blood clots and related death in cancer patients
Cleveland Clinic medical oncologist and researcher, Alok Khorana, M.D., is the primary investigator on a study that concluded rivaroxaban for venous thromboembolism (VTE), a blood clot in the venous system, significantly reduced VTE and VTE-related death for outpatient, at-risk cancer patients while they were taking the oral blood thinner. (2018-12-04)
Sex-specific effects of DHEA on bone mineral density and body composition
Women 55 and older have an increased risk of bone and muscle loss but therapy with the hormone Dehydroepiandrosterone (DHEA) may help prevent bone loss and increase muscle mass in older women, according to a new study led by Catherine M. (2018-12-04)
A new drug to prevent life-threatening swelling attacks
Patients with hereditary angioedema experience recurrent and sometimes life-threatening swelling attacks. (2018-11-28)
Phase 3 trial shows lanadelumab to be effective in reducing hereditary angioedema attacks
A phase 3 clinical trial led by a Massachusetts General Hospital physician, finds that injections of the monoclonal antibody drug lanadelumab reduced attacks of hereditary angioedema -- a rare, potentially life-threatening disorder. (2018-11-27)
New study reveals probiotics do not help children with intestinal infections
Probiotics are a multibillion-dollar industry with marketing claims of being an effective treatment for a multitude of ailments, including diarrhea. (2018-11-21)
Probiotic no better than placebo for acute gastroenteritis in children
While probiotics are often used to treat acute gastroenteritis (also known as infectious diarrhea) in children, the latest evidence shows no significant differences in outcomes, compared to a placebo. (2018-11-21)
Drug used for PTSD may worsen nightmares, not reduce suicidal thoughts
Nightmares and insomnia often accompany posttraumatic stress disorder and increase suicide risk. (2018-11-19)
Researchers find promise in new treatment for peanut allergy
Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. (2018-11-19)
MDMA makes people cooperative, but not gullible
New research from King's College London has found that MDMA, the main ingredient in ecstasy, causes people to cooperate better -- but only with trustworthy people. (2018-11-19)
Aspirin and omega-3 reduce pre-cancerous bowel polyps
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research. (2018-11-19)
VITAL study: How vitamin D and fish oil affect risk of heart attack, stroke and cancer
Brigham and Women's Hospital investigators leading the VITamin D and OmegA-3 TriaL (VITAL) conducted a rigorous placebo-controlled trial over the course of 5.3 years, gleaning a treasure trove of information on the effects of both supplements. (2018-11-10)
Compound derived from marijuana may benefit children with epilepsy
In recent years, cannabinoids -- the active chemicals in medical marijuana -- have been increasingly touted as a potential treatment for a range of neurological and psychiatric disorders. (2018-11-07)
Among heart attack survivors, drug reduces chances of second heart attack or stroke
In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke. (2018-11-07)
Study finds tennis elbow treatments provide little to no benefit
In the largest analysis to date, researchers and clinicians at Beth Israel Deaconess Medical Center (BIDMC) have compared the efficacy and safety of non-surgical treatment options for tennis elbow -- also called enthesopathy of the extensor carpi radialis brevis (eECRB). (2018-11-01)
Drug combination for treatment resistant depression no more effective than single
A large clinical trial published in the British Medical Journal today, looked at the effectiveness of adding mirtazapine to an SSRI or SNRI in patients who remain depressed after at least six weeks of conventional (SSRI or SNRI) antidepressant treatment. (2018-11-01)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#513 Dinosaur Tails
This week: dinosaurs! We're discussing dinosaur tails, bipedalism, paleontology public outreach, dinosaur MOOCs, and other neat dinosaur related things with Dr. Scott Persons from the University of Alberta, who is also the author of the book "Dinosaurs of the Alberta Badlands".